SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-22-028180
Filing Date
2022-10-12
Accepted
2022-10-11 21:09:08
Documents
9
Period of Report
2022-10-11

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 65540
2 ex1.htm EX-1 330923
3 ex2.htm EX-2 11413
4 ex3.htm EX-3 11645
5 ex4.htm EX-4 165321
6 ex5.htm EX-5 14207
7 ex1_001.jpg GRAPHIC 19193
8 ex4_001.jpg GRAPHIC 5265
9 ex5_001.jpg GRAPHIC 19193
  Complete submission text file 0001493152-22-028180.txt   660836
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 221305428
SIC: 2834 Pharmaceutical Preparations